QuantumLead homepage Services

You have accessed back-upped version of our site. Please reffer to new home page for a more up-to-date information.

Quantum Drug hit identification tool

Drug Hit Identification Tool calculates the IC50 (Kd, Ki, pKd) value of any protein-ligand complex, docks a small-molecule in the active site of a protein and performs screening a library of compounds against a target-protein or DNA/RNA. Hit Identification Tool consists of three modules: The IC50 module, 2) Ligand Docking and 3) Library Screening modules. Drug Hit Identification Tool can run both in Windows and Linux environments.

Hit Identification overview brochure IC50 (Kd, Ki, pKd) value calctulation, IC50 Prediction, molecular docking software, new inhibitor, docked ligand, molecular interaction analysis techniques, molecular simulation, Software for protein - ligand IC50 values prediction, receptor based protein ligand flexible docking, computational protein binding assay -Prediction of inhibition- IC50 predictor-activity research

Quantum Receptor Based molecular modeling technology is applicable to any resolved 3D macromolecule structure. You can order our molecular docking and virtual screening services based on molecular structure indicated below or purchase Quantum software to do docking study and other research in-house:


PDB ID: 1QBU

Title: HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY

Functional Class: Aspartyl Protease

Primary citation: Jadhav, P.K.,Ala, P.,Woerner, F.J.,Chang, C.H.,Garber, S.S.,Anton, E.D.,Bacheler, L.T. Cyclic urea amides: HIV-1 protease inhibitors with low nanomolar potency against both wild type and protease inhibitor resistant mutants of HIV. J.Med.Chem. v40 pp.181-191, 1997

Abstract Title: Cyclic urea amides: HIV-1 protease inhibitors with low nanomolar potency against both wild type and protease inhibitor resistant mutants of HIV.

Keywords: Proteins, Domain, Protease, 1qbua0, Humans, Anti-hiv, Cultured, Inhibitors, Beta, Mutation, (1qbu:a,, Proteolysis, Retroviral, D1qbub_, Viral, Cathepsin, Urea, Endopeptidase, Conformation, Immunodeficiency, Proteases, Hiv-1, Amides, Subunit, Type, Virus, Life, Structural, Protease, (retropepsin), Cells, Beta, Molecule, Microbial, Drug, 1qbub0, D1qbua_, Barrel, 5,6-dihydroxy-2-oxo-4,7-bis(phenylmethyl)-, Aspartic-type, Cycle, Acid, Protease, Sensitivity, Hiv-1, Mainly, Resistance, Activity, [4r--(1alpha,5alpha,7beta)]-3-[(cycloprophylmethyl)hexahydro-, Agents, Human, Specificity, 1h-1,3-diazepin]methyl-2-thiazolylbenzamide, Protein, Crystallography, Proteases, X-ray, Designing a ligand - a potential drug candidate, Interact specifically, Selected molecular target, Predict, In-vitro, Estimation, Determinate, Simulator, Lab, Bound, Small molecules faciliate, Modeling, Molecular modelling, Camm, Determination, Perform, Assisted, Computer assisted aided rational drug design, Structure based prediction, Estimate, Binds, 3d models, Coordinates, Measure, In-silico, Mechanisms, Advances, Inhibits, Inhibited, Bio, Biochem, Computational, Altered, Predicted values, Properties, Calculated, Appropriate, Scope, Set, Computing, Blocking, Docked, Virtual screening, Inhibiting, Native, Natural, Computational drug discovery technology, Automated, Limit, Automatic,


 
Quantum Pharmaceuticals
 

Design by Netrider.ru 2004 (c) Quantum Pharmaceuticals 2004-2008 Computer Aided Drug Design & ADMET